“From the health care payer perspective, … net cost of early use of budesonide was an additional … dollars 0.42 ( SE , dollars 0.04) per day, and the resultant cost-effectiveness ratio was US dollars 11.30 (95% CI, US dollars 8.60-US dollars 14.90) per SFD gained.”
“RESULTS Compared with usual therapy, patients receiving bu esonide ex perienced an average of 14.1 (SE, 1 .3) more SFDs per year (P <.001), fewer hospital days (69%, P <.001), and fewer emergency department visits (67%, P <.05).”